“The Corporate Scientific Advisory Board serves as an important component of the Academy’s evolving corporate partnerships, and reflects the collaborative spirit with which we seek to achieve our shared vision of effective, accessible and deliverable HIV care.”

-Bruce J. Packett, executive director

The American Academy of HIV Medicine’s Corporate Scientific Advisory Board (CSAB) is comprised of senior scientific and medical officers from pharmaceutical, biotech and diagnostic companies developing products for HIV treatment and diagnosis. The CSAB was formed 2008 to help the Academy provide its members with first-hand, up-to-date scientific pharmaceutical information on current and cutting edge HIV treatment options.

For press updates from our CSAB members, click the logos below.